AI-powered falls prevention gets the green light after successful pilot run
By
Aaron Dorman
Sep 11, 2023
A falls prevention system enhanced by AI will be officially installed soon at a memory care community operated by Maplewood Senior Living.
Alzheimer’s disease most prevalent in East, Southeast, first-ever county-level data show
By
Kimberly Bonvissuto
Jul 18, 2023
East and Southeast US states have the highest prevalence of Alzheimer’s dementia, according to the first county-level study of disease occurrence.
AI ‘can’t fly solo,’ needs humanizing context for use in healthcare, data expert emphasizes
By
Aaron Dorman
Oct 10, 2023
A researcher who builds passive AI-enabled monitoring devices believes that if more people adopted tech, it could provide invaluable data.
This clue can help ID dementia years before a formal diagnosis
By
Lois A. Bowers
Jun 03, 2024
As scientists and physicians work to improve the lives of those living with dementia now and in the future, new research contributes to the list of signs and symptoms that we can look for in friends and...
Straight from the gut: AI helps researchers confirm Alzheimer’s link
By
John O'Connor
Apr 24, 2024
Cleveland Clinic researchers are using artificial intelligence to confirm the link between the gut microbiome and Alzheimer’s disease.
Failing to cover Alzheimer’s therapies a costly proposition: researchers
By
Kimberly Bonvissuto
Jun 16, 2023
Not managing Alzheimer’s disease and related dementias is a costly proposition not just to families, but also to society, according to two recent studies.
Lawmakers chide HHS for ‘eroding the pathway’ to Alzheimer’s treatments
By
Kimberly Bonvissuto
Mar 24, 2023
With personal stories of the effects that Alzheimer’s disease has had on them, lawmakers in a Senate Finance Committee hearing on Wednesday called for the federal government to speed up access to treatments....
Novel deep-brain ‘superfiber’ could mean better Alzheimer’s imaging, diagnoses
By
Aaron Dorman
Dec 04, 2023
A novel “superfiber” could provide imaging of brain tissues in a less invasive way than conventional methods, researchers say.
Eligibility limited for anti-β amyloid mAbs in seniors with MCI
Aug 18, 2023
Few older adults with mild cognitive impairment or mild dementia were eligible for lecanemab or aducanumab after applying clinical trial criteria.
AI-driven speech analysis firm working to diagnose Alzehimer’s, Huntington’s
By
Aaron Dorman
Jun 27, 2023
A speech analysis software company is using Voice AI to diagnose depression and anxiety, and diseases like Alzheimer’s and Huntington’s could be next.